Knygos.lt klubas Knygos.lt nariams
87,35 €
-30%
Įprastai
124,79 €
Asthma therapeutic development by theophylline complex in nano-scale
Asthma therapeutic development by theophylline complex in nano-scale
Knygos.lt klubas Knygos.lt nariams
87,35 €
-30%
Įprastai
124,79 €
  • Išsiųsime per 12–18 d.d.
Asthma is one of the most common inflammatory disorders in all ages and cultures. Asthma affects all people. It is a chronic disease caused by airway blockage in the lungs. Characteristics of asthma include wheezing, tightness of the chest, and respiratory problems. Clinical signs and symptoms are used to diagnose asthma. In asthma patients with asthma, phosphodiesterase PDEs typically split off phosphorous groups and decrease cyclic Adenosine monophosphate cAMP or cyclic guanosine monophosphat…

Asthma therapeutic development by theophylline complex in nano-scale (el. knyga) (skaityta knyga) | knygos.lt

Atsiliepimai

Aprašymas

Asthma is one of the most common inflammatory disorders in all ages and cultures. Asthma affects all people. It is a chronic disease caused by airway blockage in the lungs. Characteristics of asthma include wheezing, tightness of the chest, and respiratory problems. Clinical signs and symptoms are used to diagnose asthma. In asthma patients with asthma, phosphodiesterase PDEs typically split off phosphorous groups and decrease cyclic Adenosine monophosphate cAMP or cyclic guanosine monophosphate cGMP in target cells. The amount of serum PDE increases in the cyclic extracellular nucleotides. ln this book, we review A novel synthesis-therapy in nanoscale for asthma patients by inhibits phosphodiesterase enzyme.

Knygos.lt klubas
Knygos.lt nariams
87,35 €
-30%
Įprastai
124,79 €
Kaina registruotiems pirkėjams
Prisijunkite ir už šią prekę
gausite 1,25 Knygų Eurų!?
Išsiųsime per 12–18 d.d.
Įsigykite dovanų kuponą
Daugiau

Asthma is one of the most common inflammatory disorders in all ages and cultures. Asthma affects all people. It is a chronic disease caused by airway blockage in the lungs. Characteristics of asthma include wheezing, tightness of the chest, and respiratory problems. Clinical signs and symptoms are used to diagnose asthma. In asthma patients with asthma, phosphodiesterase PDEs typically split off phosphorous groups and decrease cyclic Adenosine monophosphate cAMP or cyclic guanosine monophosphate cGMP in target cells. The amount of serum PDE increases in the cyclic extracellular nucleotides. ln this book, we review A novel synthesis-therapy in nanoscale for asthma patients by inhibits phosphodiesterase enzyme.

Atsiliepimai

  • Atsiliepimų nėra
0 pirkėjai įvertino šią prekę.
5
0%
4
0%
3
0%
2
0%
1
0%
(rodomas nebus)